Evaluation and Management of Hyperprolactinemia
Diagnostic Evaluation
- The initial assessment of galactorrhea should include a thorough history focusing on menstrual irregularity, infertility, weight changes, hirsutism, and medication use, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 2, 3
- A physical examination should be performed to assess for galactorrhea, signs of hypothyroidism, and hirsutism, according to the Journal of Neurology, Neurosurgery and Psychiatry 3
- Serum prolactin measurement is essential in the diagnosis of hyperprolactinemia, and serial measurements may be necessary to exclude stress effects, as stated in Nature Reviews Endocrinology 1
- Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels should be considered if amenorrhea is present, as suggested by the Journal of Neurology, Neurosurgery and Psychiatry 3
Etiology
- Prolactinomas account for 53% of pituitary adenomas in children and young people, according to Nature Reviews Endocrinology 1
Treatment Approach
- The treatment decision for hyperprolactinemia is based on serum prolactin level, as stated in Nature Reviews Endocrinology 1
- Dopamine agonists, preferably cabergoline, are the treatment of choice for hyperprolactinemic disorders, although the specific details of cabergoline treatment are not cited in the provided references
Monitoring and Follow-up
- Regular monitoring of reproductive function is recommended, including questioning about menstrual disorders, fertility, weight changes, hirsutism, and galactorrhea, as suggested by the Journal of Neurology, Neurosurgery and Psychiatry 2, 3 and Nature Reviews Endocrinology 1
- Particular attention should be paid to patients on valproate and obese patients, according to the Journal of Neurology, Neurosurgery and Psychiatry 2
Prognosis
- Long-term consequences of untreated hyperprolactinemia may include infertility and irregular menses, as stated in the Journal of Neurology, Neurosurgery and Psychiatry 3